Jan 8 (Reuters) - Seres Therapeutics Inc:
* SERES THERAPEUTICS SAYS HAS CASH, CASH EQUIVALENTS AND INVESTMENTS OF $171.3 MILLION, AS OF SEPT 30, 2017 - SEC FILING Source text: ( bit.ly/2qFSBN0 ) Further company coverage:
 